<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[B.C. Centre for Excellence in HIV AIDS 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=12360></link><description><![CDATA[B.C. Centre for Excellence in HIV AIDS 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 20 Jun 2026 20:02:46 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[“Genetic Test Predicts Response to Maraviroc in Treatment-Experienced HIV Patients”]]></title><link>https://www.newswire.co.kr/newsRead.php?no=419100</link><description><![CDATA[뱅쿠버--(뉴스와이어)--A genetic approach to determining HIV tropism can be used to effectively identify patients who will respond to treatment with the CCR5 antagonist maraviroc, according to new data presented  at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa.  Using screening samples fro...]]></description><pubDate>Fri, 24 Jul 2009 11:07:11 +0900</pubDate></item><item><title><![CDATA[유전자 테스트결과, 치료 경험이 있는 HIV 환자에게 Maraviroc이 효과가 있을 것으로 예측]]></title><link>https://www.newswire.co.kr/newsRead.php?no=419098</link><description><![CDATA[뱅쿠버--(뉴스와이어)--남아프리카 케이프타운에서 열린 행사 ‘5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention’ 에서 제시된 새로운 데이터에 따르면 HIV 조직 친화성을 결정하는 유전적 접근방법을 활용하여 CCR5 길항제 Maraviroc 사용 치료가 효과가 있는 환자를 파악하는 데에도 사용될 수 있다.  Maraviroc 임상 실험 프로그램에 등록하여 ...]]></description><pubDate>Fri, 24 Jul 2009 11:06:27 +0900</pubDate></item></channel></rss>